Ningbo Menovo Pharmaceutical Co (SHSE:603538) FFO


SHSE:603538 Ningbo Menovo Pharmaceutical Co Ltd SHSE:603538
62 GF Score
Price ¥43.70
GF Value ¥22.30
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Ningbo Menovo Pharmaceutical Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:603538
62GF Score
Ningbo Menovo Pharmaceutical Co Ltd SHSE:603538
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ningbo Menovo Pharmaceutical Co (SHSE:603538) Overvalued in 2026?

Based on GuruFocus' analysis, Ningbo Menovo Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥43.70 is trading 96% above its estimated GF Value™ of ¥22.30. GuruFocus considers Ningbo Menovo Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:603538:

  • FFO:
  • GF Value™: ¥22.30 vs. price of ¥43.70 (96% above fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ningbo Menovo Pharmaceutical Co Business Description

Address No.999,Yangfan Road, Room 1406, No.1, High-tech Zone, Ningbo, CHN, 315040
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
62GF Score

Get the complete analysis for SHSE:603538

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥43.70
Price
¥22.30
GF Value